97. Ulcerative colitis Clinical trials / Disease details

Clinical trials : 2,527 / Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04360343 (ClinicalTrials.gov)	July 1, 2020	6/4/2020	Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects	A Randomized, Open-label, Single Dose, 2-period, 2-sequence, 2-treatment, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects	Ulcerative Colitis	Drug: Film-coated tablet	LG Chem	NULL	Completed	19 Years	45 Years	All	18	Phase 1	Korea, Republic of
2	NCT04096573 (ClinicalTrials.gov)	April 2020	18/9/2019	Efficacy and Safety of LC51-0255 in Subjects With Ulcerative Colitis	A Phase 2, Multi Center, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Clinical Efficacy and Safety of LC51 0255 in Subjects With Moderately to Severely Active Ulcerative Colitis	Ulcerative Colitis	Drug: LC51-0255;Drug: Placebo	LG Chem	NULL	Withdrawn	18 Years	80 Years	All	0	Phase 2	NULL